New York DOJ Attorney Announces Charges Against Two Former Valeant Pharma (VRX) Execs

November 17, 2016 9:38 AM EST

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

New York Southern District DOJ Attorney Preet Bharara announces charges against Gary Tanner, a former executive at Valeant Pharmaceuticals International, Inc., (NYSE: VRX) and Andrew Davenport, the former Chief Executive Officer of Philidor Rx Services LLC, for engaging in a multi-million dollar fraud and kickback scheme.

A press conference will be held today at 12PM ET.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation, Short Sales, Trader Talk

Related Entities


Add Your Comment